Furthermore, studies have demonstrated that IFI16 enhances chemosensitivity to cisplatin and increases susceptibility to DNA damage, thereby augmenting the efficacy of chemotherapy in HCC (9). This evidence concerns the gene IFI16 and hepatocellular carcinoma.